BMY

Bristol-Myers Squibb Company

  • sector: Healthcare
  • in 1 Arithmos index

Indices that include BMY 1/1

sort
weight0.0%
alongside
  1. #1

    Recession-Resilient US Defensive 20 — Equal-Weighted

    BMY · 5.00%JNJABBVUNHMRK+15 more

    Diversified pharma with oncology, immunology, and cardiovascular franchises; 73% gross margin and 4.2% dividend yield demonstrate long-term cash generation. Equal-weighted per user specification.

    CAGR
    8.6%
    Sharpe
    0.57
    max DD
    -26.3%

Build your own index that includes BMY.

Write a plain-English prompt, get transparent rules and a 10-year backtest.

start a prompt →

Performance figures are simulated backtests, not live returns. Past performance does not predict future results. Arithmos is a research and data tool, not investment advice.

Investment research & data tool · not investment advice · not a regulated broker or advisor · past performance does not guarantee future results.